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Intravenous Inoculation of a Bat-Associated Rabies Virus
Causes Lethal Encephalopathy in Mice through Invasion
of the Brain via Neurosecretory Hypothalamic Fibers
Mirjam A. R. Preuss1,2, Marie-Luise Faber2, Gene S. Tan2, Michael Bette1, Bernhard Dietzschold2,
Eberhard Weihe1., Matthias J. Schnell2.*
1 Institute of Anatomy and Cell Biology, Department of Molecular Neuroscience, Philipps University Marburg, Marburg, Germany, 2 Jefferson Vaccine Center, Department
of Microbiology and Immunology, Thomas Jefferson University, Philadelphia, Pennsylvania, United States of America

Abstract
The majority of rabies virus (RV) infections are caused by bites or scratches from rabid carnivores or bats. Usually, RV utilizes
the retrograde transport within the neuronal network to spread from the infection site to the central nervous system (CNS)
where it replicates in neuronal somata and infects other neurons via trans-synaptic spread. We speculate that in addition to
the neuronal transport of the virus, hematogenous spread from the site of infection directly to the brain after accidental spill
over into the vascular system might represent an alternative way for RV to invade the CNS. So far, it is unknown whether
hematogenous spread has any relevance in RV pathogenesis. To determine whether certain RV variants might have the
capacity to invade the CNS from the periphery via hematogenous spread, we infected mice either intramuscularly (i.m.) or
intravenously (i.v.) with the dog-associated RV DOG4 or the silver-haired bat-associated RV SB. In addition to monitoring the
progression of clinical signs of rabies we used immunohistochemistry and quantitative reverse transcription polymerase
chain reaction (qRT-PCR) to follow the spread of the virus from the infection site to the brain. In contrast to i.m. infection
where both variants caused a lethal encephalopathy, only i.v. infection with SB resulted in the development of a lethal
infection. While qRT-PCR did not reveal major differences in virus loads in spinal cord or brain at different times after i.m. or
i.v. infection of SB, immunohistochemical analysis showed that only i.v. administered SB directly infected the forebrain. The
earliest affected regions were those hypothalamic nuclei, which are connected by neurosecretory fibers to the
circumventricular organs neurohypophysis and median eminence. Our data suggest that hematogenous spread of SB can
lead to a fatal encephalopathy through direct retrograde invasion of the CNS at the neurovascular interface of the
hypothalamus-hypophysis system. This alternative mode of virus spread has implications for the post exposure prophylaxis
of rabies, particularly with silver-haired bat-associated RV.
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skin, which have only few intraepidermal nerve fibers and therefore
are not favorable for neuronal uptake [7,8].
In contrast to natural RV infections, experimental RV
infections are commonly done by intramuscular (i.m.), intranasal
or intracerebral inoculation. Although injection into muscle
probably imitates best natural infections, it causes much less local
damage of skin, muscle tissue and microvasculature than an
animal bite. Therefore, incidental hematogenous spread due to
injury of vessels is less likely than in natural transmissions.
Our study aimed to elucidate the pathogenetic relevance of
hematogenous RV spread. In particular, we wanted to examine
whether RV is able to directly invade the brain from the vasculature
and where this invasion would preferentially take place. To
accomplish this, we infected mice i.m. or intravenously (i.v.) with
the dog-associated RV strain DOG4 or the silver-haired bat
associated RV strain SB. Both of these RV strains are highly
neuroinvasive [9], but differ greatly in their neurotropism. While

Introduction
Rabies is a fatal central nervous system (CNS) disease in
mammals, caused by rabies virus (RV), a neurotropic lyssavirus
from the family of the rhabdoviridae [1]. Generally, RV is
transmitted by scratches or bites of rabid animals, which results in
the dissemination of virions into skin and muscle tissue. After
initial infection of cells at the infection site, RV enters axon
terminals and migrates by retrograde axonal transport into the
CNS [2–4], where it causes a lethal encephalopathy. The
incubation period can vary from days to years [5,6]; however, it
is not known where the virus resides during this time.
It is likely that a part of the virus that is introduced into damaged
muscle or skin tissue after a bite is disseminated into the blood and
transported via blood circuits to the CNS. Such an event could play
a role in virus transmission by silver-haired bats where only few virus
particles are minimally invasively introduced into small patches of
PLoS Pathogens | www.plospathogens.org
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hunchback posture and hind limb paralysis. 94% of the SBinfected and 88% the DOG4-infected mice succumbed to the
infection with average survival times of 8.361.2 and 10.961.2
days, respectively. In contrast to the i.m. inoculation, only mice
that were inoculated i.v. with SB (group 3) developed rabies with a
mortality rate of 100%, while all mice which were inoculated i.v.
with DOG4 (group 4) survived. The mean survival time after SB
i.v. infection (10.462.4 days) was not significantly different from
the survival time after SB i.m. infection (p.0.05, Figure 1B).
Although the disease onset as indicated by the loss of body weight
was alike in both SB groups (Figure 1A), mice infected i.v. with SB
did not develop hind limb paralysis. Of note, i.v. injected SB
caused disease symptoms similar to those reported for intracerebral inoculation [11].

Author Summary
Rabies virus (RV) infects mammalian neurons and cycles in
regionally distinct animal populations such as the red fox
in Europe, domestic canines in Asia, or raccoons, skunks
and bats in Northern America. Although human rabies can
be prevented by pre- and post-exposure prophylaxis, more
than 50,000 people die annually from the severe
encephalopathy caused by RV. Recently, two cases of RV
transmission by organ transplantation were reported. In
our study, using intravenous inoculation of mice, we
evaluated the pathogenetic relevance of virions that reach
the bloodstream. Mice inoculated intravenously with a
canine-derived RV survived the infection in contrast to
intramuscularly injected mice, while mice infected with a
silver-haired bat-related RV succumbed to the disease
regardless of the route of inoculation. We found that the
silver-haired bat-related RV was able to transit from the
blood to the brain by invading neurosecretory fibers of the
hypothalamus, which form neurohemal synapses lacking a
blood-brain-barrier. This newly described route of brain
invasion might reflect how RV reached the central nervous
system from transplanted organs, since it takes longer to
establish the neural connections between host and grafted
tissue necessary for classical RV migration than the time
until the infection became symptomatic in the two
reported cases.

Distribution of RV Antigen in the CNS Differs after SB and
DOG4 Inoculation
Since symptoms and outcome were different between the four
experimental groups, the CNS of one mouse infected i.m. or i.v.
with SB or DOG4 was analyzed by immunohistochemistry to get
an overview of the viral distribution in the moribund stage (group
1–3) or at the end of the 20-day observation period, respectively
(group 4).
Independent from the inoculation route, SB was present in the
CNS of the two moribund animals in brainstem, cerebellum,
thalamus and neocortex (Figure 2A and 2B). However, the virus
load was more prominent in the central gray of midbrain and in
neocortical areas after i.v. inoculation as compared to i.m.
infection.
In contrast, DOG4 infected only neurons in the midbrain
tegmentum and the brainstem when injected i.m., but not in the
neocortex or the cerebellum (Figure 2C). In the brain of the i.v.
DOG4 infected mouse, no viral antigen was detectable at all
(Figure 2D). The spinal cord of this animal was also completely
free of viral antigen in contrast to the spinal cord of the mice from
the other three groups (data not shown).
On the RNA level, DOG4 genomes were detectable by
quantitative reverse transcriptase polymerase chain reaction
(qRT-PCR) over a course of at least eight months at low

DOG4 infects almost exclusively neuronal cells, SB can readily infect
other cells in vitro such as endothelial cells and fibroblasts [10].

Results
Intravenously Inoculated SB, but not DOG4, Is Highly
Pathogenic
As a first step to obtain evidence that certain RV variants might
have the capacity to reach the brain from a peripheral site via
hematogenous spread, we infected mice i.m. or i.v. with either
DOG4 or SB. After i.m. injection of 106 focus forming units (ffu) of
SB (group 1) or DOG4 (group 2), all mice developed classical
rabies symptoms like fur ruffling, weight loss (Figure 1A),

Figure 1. Strain and Inoculation Route Dependent Pathogenicity of SB and DOG4 in Mice. Six- to eight-week-old mice were inoculated
i.m. or i.v. with 106 ffu of SB or DOG4. (A) The graph depicts the weight curves of ten mice per group as group averages (mean6standard error).
Percentages relate to the body weight at the day of inoculation. (B) Kaplan-Meier plots show the survival probability per day for each experimental
group. Data are combined from two independent experiments. Survival curves were statistically different (p,0.0001) between SB i.m. (n = 16) and
DOG4 i.m. (n = 17), SB i.v. (n = 18) and DOG4 i.v. (n = 17) as well as between DOG4 i.m. and DOG4 i.v.
doi:10.1371/journal.ppat.1000485.g001
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Figure 2. Strain and Inoculation Route Dependent Distribution of Viral Antigen in the Brain. Brains of mice inoculated i.m. or i.v. with 106
ffu of SB or DOG4 were analyzed when the animals were moribund or at the end of the 20-day observation period as indicated in the panels A to D.
Sagittal sections were stained immunohistochemically against RV, subsequently visualized by an enzymatic reaction and documented with bright
field microscopy. Abbreviations: Cb, cerebellum; cc, corpus callosum; CGMB, central gray substance of midbrain; Cx, cerebral cortex; Hy,
hypothalamus; MO, medulla oblongata; RF, reticular formation; SptN, septal nuclei; Tg, midbrain tegmentum; Tec, tectum; Th, thalamus.
doi:10.1371/journal.ppat.1000485.g002

quantities, decreasing from 105 to 56102 copies per microgram
total RNA (Figure 3A). Despite the presence of viral RNA,
isolation of infectious virions from two brains 35 weeks post
infection failed, which might be explainable by the very high virus
neutralizing antibody (VNA) serum titers that were produced in all
animals (Figure 3B). These results, together with the transient
weight loss suggest that at least a transient infection of CNS tissue
after DOG4 i.v. inoculation did occur.

Progression of SB Invasion into the CNS is Different after
Intravenous and Intramuscular Inoculation
In order to analyze the migration pathways after i.v. and i.m. SB
infection, the virus load in brain and spinal cord was monitored by
qRT-PCR and immunohistochemical analysis. RNA from spinal
cord and brain tissue was harvested from mice early after
inoculation (2 hours post infection), before the onset of symptoms
(2 days post infection), at the beginning of weight loss (5 days post
infection) and in the progressed stage of disease (7 days post
infection) and analyzed for SB genomic equivalents (Figure 4A and
4B). After i.m. inoculation, genomic SB RNA was detectable in the
spinal cord in fairly low amounts only at day 2 post infection, but
the virus load rapidly increased over more than six logs within the
following three days (Figure 4A). In the brain, genomic SB RNA
was detectable in higher concentrations only at day 5 post
infection, but in very low amounts also at day 2 and even already
2 hours post infection (Figure 4B). The latter finding supported
our working hypothesis that spill over of virus into the vascular
PLoS Pathogens | www.plospathogens.org

Figure 3. Residual DOG4 RNA in the CNS and Serum VNA Titers
after i.v. Inoculation. Ten mice were infected i.v. with 106 ffu of
DOG4 and euthanized pair wise at the indicated time points. (A) The
number of RV genome equivalents per microgram total RNA isolated
from spinal cord and brain was quantified by qRT-PCR. Data are mean
RNA copy numbers (+standard error) calculated for each mouse pair. (B)
From the same mice, blood was obtained immediately before
euthanasia and VNA serum titers were determined in international
units (IU).
doi:10.1371/journal.ppat.1000485.g003
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Figure 4. Viral Burden in the CNS after SB i.m. or i.v. Inoculation. Twelve mice were infected i.m. or i.v. with 56106 ffu of SB. Three mice per
group were euthanized at each indicated time point and the number of RV genome equivalents per microgram total RNA isolated from spinal cord
(A) and brain (B) was quantified by qRT-PCR. Data are mean RNA copy numbers (+standard error) calculated for three mice per time point. Asterisks
indicate significant differences in the virus load at the indicated time point in dependence on the inoculation route (*, p,0.05).
doi:10.1371/journal.ppat.1000485.g004

is not due to the virus load in the CNS but to a difference in spatial
localization within the CNS, especially in the earlier stages of the
disease. In order to test this, the virus load in RV prone regions
such as the hippocampus, thalamic and hypothalamic nuclei, basal
ganglia, the amygdala, as well as primary and secondary
somatosensory cortex was compared by immunohistochemical
stainings against RV (Table 1; Figure 5, red bar). In the i.m.
infected mice, viral antigen was only found when an animal
exhibited first motor deficits, assessed by its performance in the
trunk curl test (morbidity status ++), and vice versa (Table 1). In
contrast, brains of i.v. infected animals did not reveal any

system and spread throughout the whole organism can occur after
i.m. inoculation. In comparison, after i.v. inoculation SB RNA was
detectable in significantly (spinal cord, p,0.05) or slightly (brain)
higher amounts especially at the early time points, whereas the
amplification slope from the day of infection to day 7 post infection
was significantly steeper in the CNS of i.m. inoculated mice
(p,0.05); this became particularly noticeable at day 5 post
infection in both CNS segments.
The similar results obtained for the two inoculation modes
regarding the extent of viral burden in the late stages of the disease
indicated that difference in clinical symptoms between the groups

Table 1. Morbidity and Virus Load at Different Time Points after i.m. or i.v. Inoculation of SB.

SB i.v.
Days post
infection
2

4

7

SB i.m.
Animal

Morbidity1

Virus load2

Days post
infection
2

Animal

Morbidity

Virus load

a1

2

2

b1

2

2

a2

2

2

b2

2

2

a3

2

2

b3

2

2

a4

2

2

b4

2

2

a5

2

++

b5

2

2

a6

2

++

b6

+

2

a7

+

2

b7

+

2

a8

+

2

b8

++

++

a9

++

2

b9

++

+

a10

++

2

b10

++

+

a11

+++

2

b11

++

+++

a12

++++

++

b12

+++

++++

4

6

Twelve mice were inoculated with 107 ffu of SB either by i.v. or i.m. injection and monitored for symptoms until mice were euthanized in a still healthy state (2 days post
infection), at the onset of weight loss (4 days post infection) and in the progressed symptomatic stage (7 days after i.v. respectively 6 days after i.m. infection). Virus load
was assessed for all animals by immunohistochemistry against RV in matched frontal brain sections (stereotaxic coordinates: interaural 2.34 mm, bregma 21.4 mm).
Animals in italic typeset were chosen for further analysis.
1
From ‘2’, no signs of illness, to ‘+++++’, morbid.
2
From ‘2’, no immunoreactivity against RV RNP, to ‘++++’, many RV RNP immunoreactive neurons and fibers in several areas.
doi:10.1371/journal.ppat.1000485.t001
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Figure 5. SB Progression within the CNS after i.m. or i.v. Inoculation. CNS tissue from four of twelve mice infected either i.v. (panel A–D) or
i.m. (panel E–H) with 107 ffu of SB was analyzed in more detail by immunohistochemical staining against RV. Animal numbers relate to Table 1. The
red bar represents the section plane (stereotaxic coordinates: interaural 2.34 mm, bregma 21.46 mm) for the initial screening of all mouse brains (see
text). Each vertical blue bar stands for another plane that was analyzed by several sections. The area caudal of the broken blue line represents the
findings for the cervical spinal cord. The background color of each plane symbolizes its percentage of SB positive structures (nuclei, fiber tracts,
cortical areas). Distinct structures were identified and counted using a stereotaxic mouse brain atlas [43]. Gray colored regions were not analyzed. The
total percentage of RV immunoreactive structures for each brain is noted in the left corner of each panel.
doi:10.1371/journal.ppat.1000485.g005

correlation between the presence of virus in the screened plane
and the morbidity status (Table 1).
Four of twelve animals were chosen from each group (Table 1,
italic typeset) for a more detailed immunohistochemical study of
on average more than 80 CNS structures. The color-coding in
Figure 5 visualizes a spatiotemporal, wavelike progression of SB
from the spinal cord and brainstem to the forebrain after i.m.
inoculation (Figure 5E–5H). In contrast, infection of spinal cord or
brainstem was not a prerequisite for infection of higher-order
structures after i.v. inoculation (Figure 5A).

fiber tracts) and their retrograde connections among each other
(Figure 6). This revealed motoneurons in the ventral horn of the
spinal cord to be the exclusive source for the further spread of SB
into the brain after i.m. inoculation (Figure 6, right). Following
i.m. inoculation, SB reached the motocortex via the pyramidal
tract, from whence it migrated to premotocortical and primary
somatosensory areas as well as motor-related brainstem nuclei
(inferior olive, reticular formation, raphe nuclei). Originating from
the olive, virus spread to the deep nuclei and the cortex of the
cerebellum. Via the reticular formation, the basal ganglia became
affected, and through the raphe nuclei, SB reached hypothalamic
nuclei as well as structures in the midbrain. During progression of
the disease, various thalamic nuclei, further hypothalamic areas,
limbic structures and other neocortical regions got infected. Only
then was virus also found in sensory-related thalamic areas (ventral
posterior complex), brainstem nuclei (dorsal column nuclei) and
spinal cord laminae in the dorsal horn.

For SB, Neurosecretory Fibers of the Neurohypophysis
and the Median Eminence Are Access Points from the
Vascular System to the Forebrain
In order to retrace viral invasion into and spread within the
CNS all immunohistochemically stained sections were further
analyzed on the level of defined structures (nuclei, cortical areas,

Figure 6. Potential Viral Invasion and Migration Pathways after i.v. (left) or i.m. (right) SB Inoculation. Potential viral migration
pathways between all RV antigen positive cortical areas and nuclei in brain and spinal cord, analyzed and identified as described in Figure 5, were
composed manually by using the BrainInfo database (http://braininfo.rprc.washington.edu/) for published efferent and afferent connections.
Depicted connections were chosen by evaluation of all possibilities with regard to the best match for each animal as well as between the animals in
dependence on time and morbidity. Presented is a simplified version, summarized on the level of hierarchically higher-ordered structures.
doi:10.1371/journal.ppat.1000485.g006
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At four days after i.v. inoculation of SB (the earliest time point,
at which viral antigen could be detected immunohistochemically),
the only SB positive structures were the hypothalamic paraventricular (PVN; Figure 7A) and supraoptic (SO; Figure 7C) nuclei,
which send neurosecretory axons to the neurohypophysis (NPH),
as well as the arcuate (ARC) nucleus (Figure 7B), which is
connected to the median eminence (ME). ME and NPH are
secretory circumventricular organs (CVO), where the usually tight
blood-brain-barrier is discontinued by fenestrated capillaries in
order to allow the release of neuron-derived hormones at
neurohemal synapses. Immunofluorescent co-stainings revealed
that SB resided in oxytocin- (Figure 7F and 7G) as well as in
antidiuretic hormone-positive (Figure 7D and 7E) fibers of the SO
and PVN. Other structures to which SB also spread while still in
the asymptomatic phase (further hypothalamic areas; basal
ganglia: striatum, globus pallidus; other telencephalic nuclei:
amygdala, nucleus accumbens, septal nuclei) were all accessible
to the virus via their efferents to the affected hypothalamic nuclei.
In the advanced stage of the disease, however, the same structures
were infected than after i.m. inoculation suggesting a late second
invasion of the CNS on conventional pathways independent from
the early infection of the basal forebrain (Figure 6, left).

DOG4 i.v. infected mice in order to clarify if the prolonged presence
of DOG4 RNA in the CNS has any pathological relevance.
The strain-specific differences in the distribution of viral antigen
in the CNS suggest that the disparity in the survivorship of mice
after i.v. inoculation of DOG4 or SB is likely due to differences in
their neurotropism [27,28]. However, they also indicate that the
symptoms in the progressed stages of the disease, which were
similar after i.m. infection with SB or DOG4 but different after i.v.
infection with SB, are not determined by the infection of particular
regions of the brain. The finding that SB was able to directly
invade neurosecretory fibers from the vascular system, while i.v.
injected DOG4 failed to establish a lethal infection of the brain by
using this way of entry, suggests that both viruses may use different
cell surface molecules that facilitate their uptake. However, since
dog- as well as bat-associated RV strains can vary substantially in
their neurotropism [9], it is possible that different bat RV strains
might actually utilize different cellular attachment molecules like
the neural cell adhesion molecule, the neurotrophin receptor
p75TNR, distinct subunits of the nicotinic acetylcholine receptor
or other yet undefined molecules, which could vary with the
specific glycoproteins of these viruses. Therefore, future experiments must reveal whether our findings can be generalized for
other canine- and bat-associates RV strains.
The migration of SB can be precisely traced after i.m.
inoculation. Immunohistochemical analysis shows that motoneurons in the spinal cord are the exclusive source for virus
progression into higher-order CNS structures; this is in agreement
with a previous study made in skunks [29]. The fact that early
infection can only be detected in the ventral horn neurons
excludes the possibility that SB uses sensory fibers in addition to
motor axons for CNS invasion from the i.m. inoculation site as it
has been proposed for other RV strains [30–32].
The observed symptoms of mice after i.v. inoculation strongly
suggest that SB directly infects the brain [11]. Our conclusion that SB
invades the CNS at the neurovascular interface of the hypothalamushypophysis system, is somewhat in conflict with an earlier report [33]
that the transit of virus into neuronal tissue occurs via infection of
ependymal cells that line the ventricles which contain the cerebral
liquor transsudated from vessels of the choroid plexus. In addition,
the possibility of passing the blood-brain-barrier via nicotinic
acetylcholine receptor-mediated endocytosis into endothelial cells of
brain capillaries [34], as it has been suggested in a recent study [35],
can be excluded by our findings. A third possibility is the invasion of
SB via CVO, which are highly vascularized sites that facilitate direct
communication of neurons with blood and liquor through fenestrated
endothelium. CVO either consist of neuronal cell bodies and sense
various circulating substances (sensory CVO), or they are formed by
neurosecretory axons and glial cells (secretory CVO). Their special
composition exposes them also as targets for invasion of pathogens,
such as trypanosoma [36]. The retrograde invasion of SB from vessels
into the CNS through neurosecretory fibers of the CVO ME and
NPH is strongly indicated, because mice sacrificed four days after i.v.
inoculation showed an almost exclusive involvement of the
hypothalamic nuclei PVN, SO and ARC. PVN and SO project
oxytocin- and antidiuretic hormon-secreting axons to the NPH, and
ARC is considered to form a functional complex together with the
ME [37], where hormones for the regulation of the adenohypophysis
are released.
In summary, our study revealed a route of brain invasion
alternative to the migration in peripheral nerves, which might be
advantageous for certain RV strains. The transit from the vascular
system to the brain via neurosecretory fibers of the ME and NPH
might also present a possible explanation for the RV infection of
immunosuppressed recipients of RV infected organs that was

Discussion
We show here that two street RV strains that are equally virulent
in mice after i.m. infection differ completely in their pathogenicity
when they are inoculated into the bloodstream. While i.v.
inoculation of DOG4 did not cause any clinical signs of rabies,
i.v. infection with SB resulted in a lethal encephalopathy. However,
the early transient weight loss together with the detection of viral
RNA in the CNS and the development of high VNA serum titers
indicate that an infection of the brain did occur after i.v. inoculation
of DOG4 but that it had apparently no or only little consequences
on the health of the animals. The presence of RV in apparently
healthy animals has been reported before [12,13] It is not known,
however, if these animals were only presymptomatic when they
were examined, or if it the infection was under control. The failure
to detect viral antigen immunohistochemically in CNS tissue of
DOG4 i.v. infected mice in spite of the presence of viral RNA can
be explained by the different sensitivities of RT-qPCR and the
histochemical analysis. In addition, the attempt to isolate virus from
the brains of two i.v. DOG4 infected mice 35 weeks pi likely failed
because of the presence of VNA in the tissue homogenates [14].
Similar observations were previously made with the neurotropic
Sindbis virus. This pathogen with a positive sense single-stranded
RNA genome causes acute encephalitis in mice, but is usually
cleared within eight days: virus isolation from brain failed as soon as
8 days pi [15], viral protein was not detectable by immunohistochemistry later than two weeks and RNA by in situ hybridization
later than 20 days pi [16,17] while demonstration of viral RNA by
RT-PCR was still successful 24 weeks after infection [18].
Antibodies constitute the main effectors against RV [19,20]. They
are able to prevent rabies when given in the presymptomatic stage
[21], or to clear apathogenic strains in experimental infections [22].
A conclusive explanation for the low and decreasing rate of virus
production we observed in the CNS of DOG4 i.v. infected mice
could be the inhibition of virus production by antibodies, a defense
mechanism that is more beneficial for the host than the killing of
virus-infected neurons [17,19,23–25]. A possible reactivation of the
DOG4 virus in the CNS and development of a lethal encephalopathy when anti-RV antibody levels have decreased cannot be
excluded, as shown for Sindbis virus [26]. Future experiments will
have to further characterize the immune and infection status of
PLoS Pathogens | www.plospathogens.org
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Figure 7. Infection of Neurosecretory Hypothalamic Neurons by SB after i.v. Inoculation. The panels show the hypothalamic
paraventricular (PVN; panel A, D and F), arcuate (ARC; panel B) and supraoptic (SO; panel C, E and G) nuclei of mice inoculated i.v. with 107 SB four
days before euthanasia. The sections were stained immunohistochemically against RV only (panel A–C) or co-stained against RV and antidiuretic
hormone (ADH; panel D and E) or oxytocin (Oxy; panel F and G). Abbreviation: 3rd V, third ventricle. Black or white bars represent 20 (panel D–G), 25
(panel B, C) or 75 mm (panel A). Arrowheads point to neurons and fibers containing both RV and ADH, or Oxy respectively.
doi:10.1371/journal.ppat.1000485.g007
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polyclonal mouse antibody Rabies NMAS 802-3 raised against
RV RNP (source: B. Dietzschold), diluted 1:300, and one of the
following antibodies: (i) rabbit-anti-oxytocin, 1:300 (ICN Biomedicals, Frankfurt am Main, Germany); (ii) rabbit-anti-antidiuretic
hormone, 1:500 (ICN Biomedicals).

reported in 2004 in the U.S.A. and in 2005 in Germany [38,39].
Transplanted tissue is deprived of direct nerval input for many
months [40]; thus the classical retrograde pathway of CNS
invasion by RV via visceromotor fibers of the autonomic nervous
system would have still been unavailable at the time of the actual
incubation for the reported transplantation incidents. Instead,
virions present in the transferred organs might have been spilled
into the recipients’ bloodstream and reached the CNS on this
newly described route.

Quantification of RV genome equivalents by qRT-PCR
RNA purification. Total RNA from solid tissue (brains and
spinal cords) was isolated using a handheld homogenizer with
disposable probes (Omni International, www.omni-inc.com/) for
disruption and the RNeasy Mini kit (Qiagen) according to the
manufacturer’s instructions.
A 15-minute on-column DNase I digest (Qiagen) was included
for all samples during the purification procedure.
Primer and TaqMan probe design. All primers and probes
for the qRT-PCR were designed by the program Primer3 (http://
frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi) using as
input the leader and RV N nucleotide sequence of the RV
strains SHBRV18 (Entrez Gene accession number: AY705373),
which is identical to that of SB, and DOG4.
Two-step qRT-PCR. One microgram of total RNA was
reverse-transcribed by using Omniscript reverse transcriptase
(Qiagen) according to the manufacturer’s protocol and a genespecific primer for genomic RV RNA (RP381, 59- ACACCCCTACAATGGATGC-39). The reactions were incubated for 1 hour
at 37uC and the enzyme was subsequently inactivated by 5 minutes
at 95uC. Quantitative PCR reactions were set up in LightCycler
capillaries (Roche Applied Science, https://www.roche-appliedscience.com/). Each 20 ml-reaction contained 16 QuantiTect
Probe PCR Master Mix (Qiagen), 500 nM forward primer
(RP381), 500 nM reverse primer (RP382 for DOG4, 59GGGTTATACAGGGCTTTTTCA-39; RP405 for SB, 59ATTCATGCCAGACAAAATTGA-39), 100 nM TaqMan probe
(RTP-3 for SB, 59-FAM-TACAAGTACCCGGCAATCAAAGACTCG-TAMRA-39; RTP-5 for DOG4, 59-FAM-CAATAATCAGGTGGTCTCTTTGAAGCCAGA-TAMRA-39) and 100 ng of
template cDNA. Reactions were performed as triplicates in a
LightCycler 1.5 instrument (Roche Applied Science) along with a
positive control triplicate and a no-template control by using the
following cycling protocol: hot start 15 minutes at 95uC;
amplification 45 cycles [15 seconds at 95uC, 60 seconds at 60uC];
cooling 30 seconds at 40uC. The fluorescence of the hydrolyzed
probes was measured in a single step at the end of each amplification
cycle, and threshold cycles were obtained by the second derivative
method through the LightCycler software v.3.5.3 (Roche Applied
Science). For absolute quantification, a standard curve was generated
for SB and DOG4 genomic RNA from serial dilutions of cDNA of a
known copy number (SB: y = 23.3773x + 42.282, R2 = 0.9998, 98%
efficiency; DOG4: y = 23.3224x + 40.973, R2 = 0.9999, 100%
efficiency) and the copy numbers were normalized to 1 mg/ml total
RNA.

Materials and Methods
Viruses
The SB strain was rescued from a cDNA clone that was derived
from the SHBRV 18 strain [28] and passaged on BSR cells. The
DOG4 strain was originally isolated from a human brain and
passaged on mouse neuroblastoma cells [9].

Mouse experiments
Six- to eight-week-old female Swiss Webster mice were
commercially obtained (NCI-Frederick Animal Production Area,
http://web.ncifcrf.gov/; Taconic Farms, http://www.taconic.
com/) and used for all in vivo studies. For i.m. infections viruscontaining Dulbecco’s phosphate buffered saline was injected into
the right gastrocnemius muscle. Intravenous inoculation was
performed by injecting virus into the heat-dilated tail vein. The
injured vein was treated with a cautery device to minimize viral
spread into the surrounding tissue by closing off the needle
puncture and severing nearby axons and nerve terminals through
which virus could be taken up from the inoculation site. Mice were
monitored and scored daily for weight changes and signs of rabies.
All animal experiments were performed according to Institutional Animal Care and Use Committee-approved protocols
(Animal Welfare Assurance no. A3085-01).

Tissue harvest
Brains and spinal cord for RNA isolation were immersed into an
appropriate amount (1 ml per 100 mg tissue) of RNAlater RNA
Stabilization reagent (Qiagen, www.qiagen.com/) immediately
after harvest from the euthanized mouse and stored at 4uC for
maximal four weeks until further processing.
Brains and spinal cords determined for immunohistochemical
analysis were immersion-fixed in Bouin Hollande fixative for
24 hours and washed with 70% isopropanol afterwards.
Brains from which infectious particles were intended to be
isolated were put promptly onto ice and processed within few hours.
Murine blood was drawn by heart puncture under isoflurane
anesthesia before euthanizing the animal. To prevent coagulation,
syringe and collection tube were flushed with 8% ethylenediamine
tetraacetic acid. Blood for serological tests was kept on ice until
centrifugation for ten minutes at 16,0006g. The serum was kept at
4uC until analysis.

VNA assay
Sera were tested for the presence of VNA using the rapid
fluorescence inhibition test [42]. The neutralizing titer, defined as
the inverse of the highest serum dilution that neutralizes 50% of
the challenge virus, was normalized to IU using the World Health
Organization anti-RV antibody standard.

Immunohistochemical analysis
Immunohistochemical stainings of CNS tissue was performed as
previously described [41].
For enzymatic immunostainings that were done to trace viral
migration pathways in the CNS, tissue sections were incubated
with a polyclonal rabbit antibody raised against the RV
ribonucleoprotein complex (RNP), diluted 1:3,000 (source: B.
Dietzschold).
Confocal double-immunofluorescence stainings were performed
to identify SB target cells in the hypothalamus-hypophysis-system.
Brain sections were incubated with a combination of the
PLoS Pathogens | www.plospathogens.org
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Brains intended for virus isolation were weighed, and sterile
Dulbecco’s phosphate buffered saline was added to get a 20%organ suspension after disruption with a handheld homogenizer
and disposable probes (Omni International). The homogenates
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were centrifuged for 10 minutes at 1,0006g. Subsequently, 100 ml
cleared homogenate were added to a cell pellet of 7.56107 murine
neuroblastoma cells, together with 10 mg DEAE-dextran and
100 ml serum-free Roswell Park Memorial Institute (RPMI) 1640
medium with L-glutamine. After 30 minutes at 37uC, the mixture
was spun down for 3 minutes at 3,0006g, and the pellet was resuspended in 1 ml 5% fetal bovine serum-containing RPMI 1640.
The cells were seeded in T25 flasks, and the volume was raised to
10 ml. After two days at 37uC, cells were stained with a FITCconjugated anti-RV N-antibody (Fujirebio Diagnostics, www.fdi.
com/) according to the manufacturer’s recommendations and
analyzed for the presence of viral antigen.

Bonferroni post tests to determine if differences in the virus load of
a tissue at the indicated time point depended on the inoculation
route. All data were analyzed using GraphPad Prism 4.0 software
(GraphPad Software, www.graphpad.com/).
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